Stereotaxis (STXS) Stock Price, Quote, News & History | Benzinga

Stereotaxis Inc (STXS) Stock Price, Quote, News & History

STXSAMEX

Trade with Public

Trade with Public

$1.44

-0.01-0.69%

At close: Aug 31, 5:00 PM EST

$1.44

0.00230.16%

After Hours: 6:29 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.49

Close

$1.44

Volume / Avg.

593.12K / 806.48K

Day Range

$1.40 - $1.49

52 Wk Range

1.24 - 3.59

Market Cap

$144.52M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

50

Short Interest

6.35%

Days to Cover

7.04

Recent Stereotaxis Inc News

Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partnership with Alabama State University.

Avi Kapoor

Stereotaxis Eyes Billions In Market Opportunity With Robocath Takeover

Stereotaxis to acquire Robocath, advancing robotic endovascular tech and accelerating expansion into cardiology and neuro markets.

Vandana Singh

This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Avi Kapoor

New Robotic System Promises Faster, Safer Care For Arrhythmia Patients

Stereotaxis (AMEX: STXS) announces first procedures with Genesis Robotic Magnetic Navigation System for minimally invasive endovascular interventions.

Triveni Kothapalli

What's Going On With Stereotaxis Shares Wednesday?

Stereotaxis shares are moving higher on Wednesday after the company announced it was accepted into the NVIDIA Connect program.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.29M

Investing Cash Flow (TTM)

-1.29M

Financing Cash Flow (TTM)

20.11M

Free Cash Flow (TTM)

-15.50M

Capital Expenditure (TTM)

-213.00K

Net Change in Cash (TTM)

3.52M

Analyst Trends and Forecast

1

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$145.21M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.67

PB Ratio (TTM)

11.87

Earnings Yield % (TTM)

-16.55%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.12

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$10.49M

Debt to Equity

0.42

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.49

Close

$1.44

Volume / Avg.

593.12K / 806.48K

Day Range

$1.40 - $1.49

52 Wk Range

1.24 - 3.59

Market Cap

$144.52M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

50

Short Interest

6.35%

Days to Cover

7.04

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and informatio...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Stereotaxis (STXS) stock?

A

You can purchase shares of Stereotaxis (AMEX:STXS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Stereotaxis (STXS) competitors?

A

Other companies in Stereotaxis’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for Stereotaxis (STXS) stock?

A

Stereotaxis has a consensus price target of $3.75.

Q

What is the current price for Stereotaxis (STXS)?

A

The stock price for Stereotaxis (AMEX: STXS) is $1.4423 last updated August 31, 2026 at 6:29 PM EDT.

Q

Does Stereotaxis (STXS) pay a dividend?

A

There are no upcoming dividends for Stereotaxis.

Q

When is Stereotaxis (AMEX:STXS) reporting earnings?

A

Stereotaxis does not have any upcoming earnings scheduled.

Q

Is Stereotaxis (STXS) going to split?

A

There is no upcoming split for Stereotaxis.

Q

What sector and industry does Stereotaxis (STXS) operate in?

A

Stereotaxis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the AMEX.